Fengfei Xie

436 total citations
14 papers, 339 citations indexed

About

Fengfei Xie is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Fengfei Xie has authored 14 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Fengfei Xie's work include RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Fengfei Xie is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Fengfei Xie collaborates with scholars based in China, Czechia and United States. Fengfei Xie's co-authors include Peng George Wang, Dimitri Papukashvili, Nino Rcheulishvili, Gang Liu, Yunjiao He, Yesi Shi, Xingyun Wang, Chen Hu, Dan Mu and Rongjuan Chen and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and Biochemical and Biophysical Research Communications.

In The Last Decade

Fengfei Xie

13 papers receiving 333 citations

Peers

Fengfei Xie
Lucas Shores United States
Jeremy S. Blum United States
Changsik Shin South Korea
Sean H. Kelly United States
Jessica M. Banks United States
Fengfei Xie
Citations per year, relative to Fengfei Xie Fengfei Xie (= 1×) peers Jiang Bian

Countries citing papers authored by Fengfei Xie

Since Specialization
Citations

This map shows the geographic impact of Fengfei Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfei Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfei Xie more than expected).

Fields of papers citing papers by Fengfei Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengfei Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfei Xie. The network helps show where Fengfei Xie may publish in the future.

Co-authorship network of co-authors of Fengfei Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Fengfei Xie. A scholar is included among the top collaborators of Fengfei Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengfei Xie. Fengfei Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wang, Ziqian, Xingwu Liu, Jiahui Jin, et al.. (2025). PEG‐Free Monosialoganglioside Lipid Nanoparticles with Spleen‐Selective mRNA Delivery for Cancer Immunotherapy. Advanced Functional Materials. 36(1).
2.
Hu, Xing, Nino Rcheulishvili, Yunzhi Wang, et al.. (2025). Development and efficacy of a novel mRNA cocktail for the delivery of African swine fever virus antigens and induction of immune responses. Microbiology Spectrum. 13(6). e0290924–e0290924. 2 indexed citations
3.
Papukashvili, Dimitri, Nino Rcheulishvili, Fengfei Xie, et al.. (2023). DKK1-targeting cholesterol-modified siRNA implication in hair growth regulation. Biochemical and Biophysical Research Communications. 668. 55–61. 5 indexed citations
4.
Liu, Cong, et al.. (2023). Development of a Library of Disulfide Bond-Containing Cationic Lipids for mRNA Delivery. Pharmaceutics. 15(2). 477–477. 12 indexed citations
5.
Wang, Xingyun, Nino Rcheulishvili, Dimitri Papukashvili, et al.. (2023). Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa. npj Vaccines. 8(1). 76–76. 48 indexed citations
6.
Liu, Cong, Dimitri Papukashvili, Yu Dong, et al.. (2022). Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype. Frontiers in Cell and Developmental Biology. 9. 783527–783527. 18 indexed citations
7.
Rcheulishvili, Nino, Dimitri Papukashvili, Cong Liu, et al.. (2022). Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic/pandemic preparedness. International Journal of Biological Macromolecules. 226. 885–899. 25 indexed citations
8.
Wang, Xingyun, Nino Rcheulishvili, Jie Cai, et al.. (2022). Development of DNA Vaccine Candidate against SARS-CoV-2. Viruses. 14(5). 1049–1049. 9 indexed citations
10.
Liu, Cong, Nino Rcheulishvili, Dimitri Papukashvili, et al.. (2022). Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants. Pharmaceutics. 14(5). 1101–1101. 18 indexed citations
11.
Papukashvili, Dimitri, Nino Rcheulishvili, Cong Liu, et al.. (2021). Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy. Cells. 10(11). 2957–2957. 28 indexed citations
12.
Shi, Yesi, Fengfei Xie, Hongyan Qian, et al.. (2020). TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy. Journal of Controlled Release. 320. 304–313. 85 indexed citations
13.
Gao, Haiyan, Chengchao Chu, Yi Cheng, et al.. (2020). In Situ Formation of Nanotheranostics to Overcome the Blood–Brain Barrier and Enhance Treatment of Orthotopic Glioma. ACS Applied Materials & Interfaces. 12(24). 26880–26892. 48 indexed citations
14.
Shi, Yesi, Junqing Wang, Jingyi Liu, et al.. (2019). Oxidative stress-driven DR5 upregulation restores TRAIL/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer. Biomaterials. 233. 119753–119753. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026